Clinical Trial

Sbrt±sTad for Unfavorable iNtermediate rIsk/High Risk Prostate caNcer

Name: Sbrt±sTad for Unfavorable iNtermediate rIsk/High Risk Prostate caNcer — clinical trial record (NCT05557604)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: STUNNIN

Recruiting Phase 2

View on ClinicalTrials.gov →

Record status

This record was last updated September 28, 2022 (before its estimated February 2, 2024 completion). Its status may not reflect the trial's current state.

Summary

This is a prospective, open, randomized phase II trial.

Trial Details

NCT Number	NCT05557604
Lead Sponsor	Regina Elena Cancer Institute
Conditions	Prostate Cancer
Enrollment	146 participants
Start Date	2021-02-02
Primary Completion	2024-02-02 (estimated)
Study Completion	2027-02-02 (estimated)
Updated on ClinicalTrials.gov	2022-09-28